Acurx Pharmaceuticals, Inc.
ACXP
$0.335
$0.0051.52%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 20.53% | -29.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.41% | -31.54% | |||
| Operating Income | 1.41% | 31.54% | |||
| Income Before Tax | 1.41% | 31.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.41% | 31.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.41% | 31.54% | |||
| EBIT | 1.41% | 31.54% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 4.70% | 33.82% | |||
| Normalized Basic EPS | 4.73% | 33.78% | |||
| EPS Diluted | 4.70% | 33.82% | |||
| Normalized Diluted EPS | 4.73% | 33.78% | |||
| Average Basic Shares Outstanding | 3.46% | 3.40% | |||
| Average Diluted Shares Outstanding | 3.46% | 3.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
